PERMANENT AWARD EVIDENCE
University of Bristol · published 9 Feb 2026. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.
1a1a7d80-38ee-4ac0-94c9-ff186da4683e-882863ocds-b5fd17-382ed01d-c684-44de-8801-60dbb1cd9b28GB-CFS-283030A tender estimate and an award value answer different questions. Neither is treated as cash paid.
MRC Sleep Study - Purchase of IMP to include the following activities: - Support with regulatory approvals (preparation of IMPD) - Sourcing of Trazodone 100mg tablets & Zolpidem 5mg tablets - Over-encapsulation of active products & Manufacture of matched placebo capsules) - Packaging of products in to bottles, designing and providing blinded labels in accordance with Medicines for Human Use (Clinical Trials) Regulations 2004 and the 2025 Amendment to Regulations - Hold appropriate MIA(IMP) authorisation - QP Certification for use in the UK - Storage & Distribution to UK Pharmacy - Ensure full traceability of materials and processes, including batch release certificates and audit trails - Conducting such work as instructed, and in accordance with any relevant protocol / policy / work-instruction, for the duration of the contract. - Compliance with Medicines for Human Use (Clinical Trials) Regulations 2004 and the 2025 Amendment to Regulations when they are applied in April 2026 plus any other applicable regulatory requirements
The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.
A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.
No supplier is named in this projection. That does not prove the notice had no supplier in every source version.
Published 9 Feb 2026 · held through the daily award projection · Open Government Licence v3.0.